Neovascular Age-Related Macular Degeneration: Developing Drugs for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 24, 2023
March 3, 2023
3b32c08c-4e69-42f4-ba19-cda20a8af050
Related Documents
Master Protocols for Drug and Biological Product Development
Guidance DocumentDecember 21, 2023Center for Drug Evaluation and Research
Labeling for Biosimilar and Interchangeable Biosimilar Products
Guidance DocumentSeptember 18, 2023Center for Drug Evaluation and Research
Fabry Disease: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 7, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox